Of Mice and Men Avandia and Heart Attacks

A research report published on-line September 6 in the Journal of Clinical Investigation may provide important clues as to why GlaxoSmithKline's diabetes drug Avandia has such a deadly effect on some diabetics.

Former Wyeth Salesman Testifies Company Downplayed Risks

A former salesman for pharmaceutical giant Wyeth testified that he was coached by the company to downplay studies showing its hormone replacement drug Prempro increased a woman's risk for breast cancer.

Actos Bests Avandia in New Study

Already under attack for potential heart risks, the diabetes drug Avandia is taking fresh hits from two new studies published Sept. 11 in the Journal of the American Medical Association.

Reports of Drug Side Effects Rise

U.S. regulators received more than twice as many reports of deadly or debilitating side effects from drug treatment in 2005 as they did seven years before, a study found.

Avandia Should be Pulled, say Authors of Studies

Two studies and an editorial today should lead the Food and Drug Administration to pull the diabetes pill Avandia off the market, the authors say.

More Studies Cast Doubt on Safety of Diabetes Drug

Two more studies published in yet another prominent medical journal have raised questions about the safety of Avandia, a once-popular diabetes medicine.

Avandia Safety Questioned by More Studies

Avandia has come under fire again, after two more studies raised additional concerns over the safety of the diabetes medication.

Burden of Proof

Pointing to risks linked to FDA-approved drugs, a researcher argues that the agency should require more testing, a route some say could keep life-saving medication off the market for years

3 Nevadans take on Drugmaker

The women have shared the trauma of facing a cancer that threatened their lives. But they have another factor in common: years spent taking hormone replacement therapy drugs to counter the effects of menopause.

3 Nevada Women take on Drug Maker in Hormone Replacement Trial

Three northern Nevada women are scheduled to go to trial this week against Wyeth Pharmaceuticals in the latest lawsuit claiming that the company's hormone replacement drugs cause breast cancer.